Palogen's biosensor can change the paradigm of clinical diagostics to date.
Even the smallest amounts of DNA - with no PCR - can deliver industry-leading sensitivity and specificity while dramatically reducing diagnosis time and cost.
With general CMOS technology.
Why Genomic Sensor is a breakthrough in genomic diagnosis ?
The key to genomic diagnosis so far has been derived from how much DNA can be extracted with genetic characteristics.
In order to obtain information from a limited supply of DNA, amplification is necessary, which is the reason for the development of PCR technology.
However, the PCR process inevitably leads to the denaturation of DNA which degrades diagnostic performance.
Even a small amount of DNA can provide more accurate diagnostic results than conventional ones. Furthermore, this sensor is manufactured using a semiconductor process, so there is no cost burden.
Palogen is building upon this advantage to create a new paradigm in the field of DNA screening.
The sensor ASIC provides the ability to convert the microcurrent output by the biosensor into a digital signal through noise reduction,
signal amplification and an ADC. Changes in digital patterns due to changes in the nucleotide sequences are transmitted to the AI Based Diagnostic Platform,
and the presence of disease can be determined in the shortest time in the industry. By integrating analog circuits capable of high-performance signal processing.
World-class detection power based on high performance biosensor
No PCR, and the highest level of sensitivity/specificity even with very small amounts of DNA
Laboratory B-1713, 5th Seongnam Woorim Lions Valley, 302, Galmachi-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of KoreaFactory B-1704, 5th Seongnam Woorim Lions Valley, 302, Galmachi-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of KoreaU.S.A 39655 Eureka Drive, Newark, CA 94560, United States